Conformational Differences between Functional Human Immunodeficiency Virus Envelope Glycoprotein Trimers and Stabilized Soluble Trimers

被引:24
|
作者
Castillo-Menendez, Luis R. [1 ]
Nguyen, Hanh T. [1 ]
Sodroski, Joseph [1 ,2 ]
机构
[1] Harvard Med Sch, Dept Canc Immunol & Virol, Dana Farber Canc Inst, Dept Microbiol & Immunobiol, Boston, MA 02115 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
conformation; cross-linker; envelope glycoprotein; human immunodeficiency virus; mass spectrometry; stabilization; structure; trimer; CHEMICAL CROSS-LINKING; CRYO-EM STRUCTURE; CELL-SURFACE EXPRESSION; CYTOPLASMIC DOMAIN; MASS-SPECTROMETRY; NEUTRALIZING ANTIBODIES; CRYSTAL-STRUCTURE; TYPE-1; ENV; HIV-1; GP41; MOLECULAR ARCHITECTURE;
D O I
10.1128/JVI.01709-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Binding to the receptor CD4 triggers entry-related conformational changes in the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer, (gp120/gp41)(3). Soluble versions of HIV-1 Env trimers (sgp140 SOSIP.664) stabilized by a gp120-gp41 disulfide bond and a change (I559P) in gp41 have been structurally characterized. Here, we use cross-linking/mass spectrometry to evaluate the conformations of functional membrane Env and sgp140 SOSIP.664. Differences were detected in the gp120 trimer association domain and C terminus and in the gp41 heptad repeat 1 (HR1) region. Whereas the membrane Env trimer exposes the gp41 HR1 coiled coil only after CD4 binding, the sgp140 SOSIP.664 HR1 coiled coil was accessible to the gp41 HR2 peptide even in the absence of CD4. Our results delineate differences in both gp120 and gp41 subunits between functional membrane Env and the sgp140 SOSIP.664 trimer and provide distance constraints that can assist validation of candidate structural models of the native HIV-1 Env trimer. IMPORTANCE HIV-1 envelope glycoprotein spikes mediate the entry of the virus into host cells and are a major target for vaccine-induced antibodies. Soluble forms of the envelope glycoproteins that are stable and easily produced have been characterized extensively and are being considered as vaccines. Here, we present evidence that these stabilized soluble envelope glycoproteins differ in multiple respects from the natural HIV-1 envelope glycoproteins. By pinpointing these differences, our results can guide the improvement of envelope glycoprotein preparations to achieve greater similarity to the viral envelope glycoprotein spike, potentially increasing their effectiveness as a vaccine.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Expression and processing of the human immunodeficiency virus type 1 envelope glycoprotein
    Chen, SSL
    INTERVIROLOGY, 1996, 39 (04) : 242 - 248
  • [42] DYNAMIC EQUILIBRIUM BETWEEN VESICULAR STOMATITIS-VIRUS GLYCOPROTEIN MONOMERS AND TRIMERS IN THE GOLGI AND AT THE CELL-SURFACE
    ZAGOURAS, P
    ROSE, JK
    JOURNAL OF VIROLOGY, 1993, 67 (12) : 7533 - 7538
  • [43] Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies
    Sullivan, N
    Sun, Y
    Binley, J
    Lee, J
    Barbas, CF
    Parren, PWHI
    Burton, DR
    Sodroski, J
    JOURNAL OF VIROLOGY, 1998, 72 (08) : 6332 - 6338
  • [44] COMPUTER-PREDICTIONS OF FUNCTIONAL, TOPOGENIC, AND ANTIGENIC DOMAINS IN HUMAN IMMUNODEFICIENCY VIRUS-2 ENVELOPE GLYCOPROTEIN
    BECKER, Y
    VIRUS GENES, 1992, 6 (01) : 79 - 93
  • [45] OLIGOMERIC STRUCTURE OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN
    EARL, PL
    DOMS, RW
    MOSS, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) : 648 - 652
  • [46] Antigenicity of truncated forms of the human immunodeficiency virus type 1 envelope glycoprotein
    Jeffs, SA
    McKeating, J
    Lewis, S
    Craft, H
    Biram, D
    Stephens, PE
    Brady, RL
    JOURNAL OF GENERAL VIROLOGY, 1996, 77 : 1403 - 1410
  • [47] Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum
    Land, A
    Braakman, I
    BIOCHIMIE, 2001, 83 (08) : 783 - 790
  • [48] Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization
    Chakrabarti, BK
    Kong, W
    Wu, B
    Yang, ZY
    Friborg, J
    Ling, X
    King, SR
    Montefiori, DC
    Nabel, GJ
    JOURNAL OF VIROLOGY, 2002, 76 (11) : 5357 - 5368
  • [49] Functional differences between human and bovine immunodeficiency virus tar transcription factors
    Bogerd, HP
    Wiegand, HL
    Bieniasz, PD
    Cullen, BR
    JOURNAL OF VIROLOGY, 2000, 74 (10) : 4666 - 4671
  • [50] Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
    Beddows, S
    Schülke, N
    Kirschner, M
    Barnes, K
    Franti, M
    Michael, E
    Ketas, T
    Sanders, RW
    Maddon, PJ
    Olson, WC
    Moore, JP
    JOURNAL OF VIROLOGY, 2005, 79 (14) : 8812 - 8827